The dedicated billing code, 0640U, effective July 1, 2026, establishes a unique reimbursement identifier for the CNSide CSF TCE test, supporting payer claims processing and facilitating broader ...

With its latest obesity play appearing to pay off, Regeneron has turned its attention to radiopharmaceuticals. | With its latest obesity play appearing to pay off, Regeneron has turned its attention ...

Shares in CRISM Therapeutics (AIM: CRTX) rose 12% to 13.4p on Tuesday after the clinical-stage drug delivery company ...

To model tumor biology, Emulate’s platform introduces stromal contents by tuning the extracellular matrix stiffness and composition, as well as recreating essential gradients. The method captures ...

In a deal potentially worth more than $3 billion, radiopharmaceuticals developer Telix has struck a deal to develop next-gen ...

Convergent Therapeutics' Dr. Philip Kantoff and Plus Therapeutics' Dr. Marc Hedrick discuss how unmet medical needs, maturing ...

PM Eastern, Lantern Pharma will host an exclusive live demonstration of withZeta.ai at Nasdaq MarketSite in New York City - one of the world's most recognized venues for presenting innovation to the ...

Telix Pharmaceuticals Limited TLX shares are up during Monday’s premarket session following a significant collaboration ...

Merck built a wall of patents to keep a cancer drug's price – and its profits – high. Hospitals often add to the cost for ...

The Shelby County Board of Commissioners will meet for its regular meeting on March 30 at 3 p.m. The public can attend in person at the Vasco A. Smith, Jr. County Administration Building, located at ...

Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the brain and other difficult-to-reach ...